Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Zoetis Inc
ZTS
Healthcare
Drug Manufacturers - Specialty & Generic
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep...
; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its pro...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NYSE:ZTS)
New Post
View:
Posts & Comments
Threaded Posts
(2)
•••
higherhighs
X
Comment by
higherhighs
on Jan 04, 2025 9:32am
RE:Breakout Imminent !!!!
$PETV The studies will show dramatic benefits to the dogs, the same as horses. The granulated matrix of heparin, collagen and elastin when injected becomes sponge-like creating a lubricated
...more
(2)
•••
higherhighs
X
Post by
higherhighs
on Jan 02, 2025 9:25am
Breakout Imminent !!!!
$PETV Happy new year to this board! I believe Petv will be one of the biggest percentage gainers this year! Why? first the Company is reaping the benefit of its marketing in reaching small animal Vets
...more
Initial Assay Results From the First Five Holes of the 2025 Drilling Program
posted Dec 10, 2025 9:00am by
Viridian Metals Inc.
-
|
Several holes returned >20-metre mineralized intervals, including local high-grade copper zones such as 1.38% Cu (2.14% CuEq¹) over 0.7 metres from 4.45 metres depth. These strong early results reinforce Kraken as one of the shallowest and most laterally extensive magmatic sulphide systems in Canada ...read more
(2)
•••
higherhighs
X
Post by
higherhighs
on Dec 20, 2024 9:00am
Breakout Imminent !!!!
$PETV Thete are 83 million dogs in the US alone. ZTS achieved $400 mill in sales for Librela for dog arthritis in the US. Given that the price is about $160 per month this means they achieved about
...more
(16)
•••
frebeach1
X
Comment by
frebeach1
on Aug 23, 2024 1:37pm
RE:Elanco poses a real threat here
Investors invited to comment on possible Security Violations. Ck their bullboard.
(5)
•••
TrickyGuy
X
Post by
TrickyGuy
on Mar 04, 2024 3:44pm
Elanco poses a real threat here
Elanco Animal Health is #2 in animal pharmaceuticals. Zoetis has 15 Blockbuster drugs (>$100 million in sales) and has been a stock market darling. #1 in Companion animals (mostly dogs and
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Lode Gold Enters into Exclusive LOI with a Mining Company to Advance Fremont Gold Project